← Back to the full Peptide Guide overview
Important Disclaimer — Read Before Using This Page
This information is not intended for use by unlicensed individuals or by licensed professionals who lack adequate training and experience in assessing patients for peptide or hormone therapy. All clinical decisions and dosing must be made in consultation with a licensed, experienced physician and a licensed, experienced compounding pharmacist, and should be supported by published clinical studies.
The information presented here has been compiled using Artificial Intelligence, statements from videos and websites by apparent qualified professionals, and available published research. We strongly encourage exhaustive independent research before considering any therapy. Anyone starting a medication they have never taken before should take an extremely conservative approach.
Nothing on this page or in these videos should be taken as medical advice. These materials are provided only to help begin your research. All dosing and treatment decisions should be made between you and your medical providers after proper evaluation. We are not affiliated with any of the doctors whose videos appear on this page.
Sermorelin Compounded
Category: Growth Hormone-Releasing Hormone (GHRH) Analog
How it works. Sermorelin is a synthetic analog of growth hormone-releasing hormone (GHRH). It tells the pituitary gland to release the patient's own growth hormone in a pulsatile, physiologic pattern. This matters because the pituitary feedback system stays intact: when growth hormone rises, somatostatin feedback kicks in, IGF-1 rises through the normal downstream pathway, and the body regulates itself. That is the theoretical safety advantage of sermorelin over direct recombinant growth hormone injection, where IGF-1 can climb without the same endogenous restraint.
Why a physician prescribes it. Sermorelin is most defensibly prescribed for carefully selected adults with symptoms and lab patterns suggesting age-related growth-hormone-axis decline ("somatopause")—poor sleep quality, impaired recovery, reduced exercise tolerance, or specific body-composition concerns. It is most credible when framed as physiologic stimulation rather than as an aggressive anti-aging transformation. The patient who wants to look twenty-five again at age fifty-five is going to be disappointed. The patient who wants better sleep, gradual recovery improvement, and modest body-composition changes over months is much more likely to be satisfied.
What to know before starting. Sermorelin is not appropriate for patients with active or recent cancer, pituitary tumors, poorly controlled diabetes, or edema-prone conditions. The adult evidence base is thinner than most patients assume—most robust data comes from pediatric growth-hormone-deficiency testing and older adult pharmacology studies, not from large randomized outcome trials in middle-aged wellness patients. Because it is a compounded product from a 503A pharmacy, sterility and potency depend on the specific pharmacy your prescriber uses. Patients typically notice better sleep first, often within two to four weeks—that is a real and reproducible effect, because growth-hormone pulsatility is tightly linked to slow-wave sleep.
Recommended Videos
Chancellor Harn, ND, MS — Sermorelin: The Peptide for Growth Hormone Optimization in Anti-Aging Medicine
Video Sources & Independence
The videos linked on this page are provided solely for educational purposes. None of the physicians or channels featured are sponsored by, affiliated with, or compensated by NJ Weight Loss & Preventive Care Clinics, its physicians, or any individuals associated with our practice. We have selected these videos because they offer thoughtful, evidence-based discussion of mechanisms and clinical considerations. Viewers should evaluate all sources independently.
← Back to the full Peptide Guide overview · Peptide Dosing Reference →